Aurora A anticorps
Aperçu rapide pour Aurora A anticorps (ABIN2477554)
Antigène
Voir toutes Aurora A (AURKA) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Réactivité croisée
- Souris
-
Attributs du produit
- Purified IgG
-
Purification
- Purified
-
Isotype
- IgG2b
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.0 mg/mL
-
-
-
: "Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target." dans: Leukemia, Vol. 27, Issue 3, pp. 560-8, (2013) (PubMed).
: "Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells." dans: Haematologica, Vol. 98, Issue 10, pp. 1539-46, (2013) (PubMed).
: "Preparation and characterization of a human aurora-A kinase monoclonal antibody." dans: Molecular and cellular biochemistry, Vol. 243, Issue 1-2, pp. 123-31, (2003) (PubMed).
-
: "Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target." dans: Leukemia, Vol. 27, Issue 3, pp. 560-8, (2013) (PubMed).
-
- Aurora A (AURKA) (Aurora Kinase A (AURKA))
-
Autre désignation
- AURORA-A KINASE
-
Sujet
- Synonyms: SERINE/THREONINE KINASE 15
-
ID gène
- 6790
-
UniProt
- O14965
-
Pathways
- Cycle Cellulaire, Asymmetric Protein Localization
Antigène
-